503 related articles for article (PubMed ID: 34468753)
21. Impact of a hyperglycemic crises protocol.
Hara JS; Rahbar AJ; Jeffres MN; Izuora KE
Endocr Pract; 2013; 19(6):953-62. PubMed ID: 23807521
[TBL] [Abstract][Full Text] [Related]
22. Access to Specialty Care for Commercially Insured Youths With Type 1 and Type 2 Diabetes.
March CA; Byerly AR; Siminerio L; Miller E; Rothenberger S; Libman I
JAMA Netw Open; 2024 Apr; 7(4):e245656. PubMed ID: 38578636
[TBL] [Abstract][Full Text] [Related]
23. Pediatric Diabetic Ketoacidosis With Hyperosmolarity: Clinical Characteristics and Outcomes.
Agrawal S; Baird GL; Quintos JB; Reinert SE; Gopalakrishnan G; Boney CM; Topor LS
Endocr Pract; 2018 Aug; 24(8):726-732. PubMed ID: 30084686
[TBL] [Abstract][Full Text] [Related]
24. Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.
Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Gevers EF; Stephenson T
Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295580
[TBL] [Abstract][Full Text] [Related]
25. Predictors of acute complications in children with type 1 diabetes.
Rewers A; Chase HP; Mackenzie T; Walravens P; Roback M; Rewers M; Hamman RF; Klingensmith G
JAMA; 2002 May; 287(19):2511-8. PubMed ID: 12020331
[TBL] [Abstract][Full Text] [Related]
26. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
[TBL] [Abstract][Full Text] [Related]
27. Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin, 1988-2020.
Venkatraman S; Echouffo-Tcheugui JB; Selvin E; Fang M
JAMA Netw Open; 2022 Dec; 5(12):e2247656. PubMed ID: 36538330
[TBL] [Abstract][Full Text] [Related]
28. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes.
Alexopoulos AS; Kahkoska AR; Pate V; Bradley MC; Niznik J; Thorpe C; Stürmer T; Buse J
JAMA Netw Open; 2021 Nov; 4(11):e2132215. PubMed ID: 34726745
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a real-world model to predict 1-year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States).
Ratzki-Leewing AA; Black JE; Ryan BL; Zou G; Klar N; Webster-Bogaert S; Timcevska K; Harris SB
Diabetes Obes Metab; 2023 Oct; 25(10):2910-2927. PubMed ID: 37409569
[TBL] [Abstract][Full Text] [Related]
30. Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy.
Chou WY; Li YR; Chan WK; Chen ST
Biomed J; 2018 Dec; 41(6):348-355. PubMed ID: 30709576
[TBL] [Abstract][Full Text] [Related]
31. [Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases].
Vavricka SR; Walter RB; Brändle M; Ballmer PE; Haller A
Dtsch Med Wochenschr; 2002 Nov; 127(46):2441-6. PubMed ID: 12432484
[TBL] [Abstract][Full Text] [Related]
32. Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.
Tittel SR; Sondern KM; Weyer M; Poeplau T; Sauer BM; Schebek M; Ludwig KH; Hammer F; Fröhlich-Reiterer E; Holl RW;
Acta Diabetol; 2020 Oct; 57(10):1245-1253. PubMed ID: 32488499
[TBL] [Abstract][Full Text] [Related]
33. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
McCoy RG; Lipska KJ; Van Houten HK; Shah ND
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors for Hyperosmolar Hyperglycemic State in Pediatric Type 2 Diabetes.
Everett EM; Copeland T; Wisk LE; Chao LC
Pediatr Diabetes; 2023; 2023():. PubMed ID: 37614411
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin A1c and Type 2 Diabetes Incidence Among Adolescents With Overweight and Obesity.
Hoe FM; Darbinian JA; Greenspan LC; Lo JC
JAMA Netw Open; 2024 Jan; 7(1):e2351322. PubMed ID: 38231515
[TBL] [Abstract][Full Text] [Related]
36. Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study.
Ebrahimi F; Kutz A; Christ ER; Szinnai G
Front Endocrinol (Lausanne); 2022; 13():940990. PubMed ID: 36093075
[TBL] [Abstract][Full Text] [Related]
37. Incidence and Characteristics of the Hyperosmolar Hyperglycemic State: A Danish Cohort Study.
Rosager EV; Heltø ALK; Fox Maule CU; Friis-Hansen L; Petersen J; Nielsen FE; Haugaard SB; Gregersen R
Diabetes Care; 2024 Feb; 47(2):272-279. PubMed ID: 38085699
[TBL] [Abstract][Full Text] [Related]
38. Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period.
Wu XY; She DM; Wang F; Guo G; Li R; Fang P; Li L; Zhou Y; Zhang KQ; Xue Y
BMC Endocr Disord; 2020 Dec; 20(1):182. PubMed ID: 33317485
[TBL] [Abstract][Full Text] [Related]
39. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
Umpierrez GE; Clark WS; Steen MT
Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964
[TBL] [Abstract][Full Text] [Related]
40. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
